ATC code J06: Difference between revisions
m 1 revision imported |
CSV import |
||
| Line 48: | Line 48: | ||
{{Immune sera and immunoglobulins}} | {{Immune sera and immunoglobulins}} | ||
[[Category:ATC codes|J06]] | [[Category:ATC codes|J06]] | ||
{{No image}} | |||
Revision as of 05:07, 10 February 2025
| ATC codes |
|---|
| J Antiinfectives for systemic use |
| J01 Antibacterials for systemic use |
| J02 Antimycotics for systemic use |
| J04 Antimycobacterials |
| J05 Antivirals for systemic use |
| Human only |
| J06 Immune sera and immunoglobulins |
| J07 Vaccines |
| ATCvet only |
| QJ51 Antibacterials for intramammary use |
| QJ54 Antimycobacterials for intramammary use |
|
A
B
C
D
G
H
QI
J
L
M
N
P
R
S
V
|
ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>
ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.
</ref><ref>
ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.
</ref> Subgroup J06 is part of the anatomical group J Antiinfectives for systemic use.<ref>
ATC/DDD Index 2022
- code J06(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.
</ref>
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J06A Immune sera
J06AA Immune sera
- J06AA01 Diphtheria antitoxin
- J06AA02 Tetanus antitoxin
- J06AA03 Snake venom antiserum
- J06AA04 Botulinum antitoxin
- J06AA05 Gas-gangrene sera
- J06AA06 Rabies serum
J06B Immunoglobulins
J06BA Immunoglobulins, normal human
- J06BA01 Immunoglobulins, normal human, for extravascular administration
- J06BA02 Immunoglobulins, normal human, for intravascular administration
J06BB Specific immunoglobulins
- J06BB01 Anti-D (rh) immunoglobulin
- J06BB02 Tetanus immunoglobulin
- J06BB03 Varicella/zoster immunoglobulin
- J06BB04 Hepatitis B immunoglobulin
- J06BB05 Rabies immunoglobulin
- J06BB06 Rubella immunoglobulin
- J06BB07 Vaccinia immunoglobulin
- J06BB08 Staphylococcus immunoglobulin
- J06BB09 Cytomegalovirus immunoglobulin
- J06BB10 Diphtheria immunoglobulin
- J06BB11 Hepatitis A immunoglobulin
- J06BB12 Encephalitis, tick-borne immunoglobulin
- J06BB13 Pertussis immunoglobulin
- J06BB14 Morbilli immunoglobulin
- J06BB15 Parotitis immunoglobulin
- J06BB16 Palivizumab
- J06BB17 Motavizumab
- J06BB18 Raxibacumab
- J06BB19 Anthrax immunoglobulin
- J06BB21 Bezlotoxumab
- J06BB22 Obiltoxaximab
- J06BB30 Combinations
J06BC Other immunoglobulins
- J06BC01 Nebacumab
See also
References
<references group="" responsive="1"></references>
| Immune sera and immunoglobulins (J06) | ||||
|---|---|---|---|---|
|